Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110


Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts.

Ueno T, Dutta P, Keliher E, Leuschner F, Majmudar M, Marinelli B, Iwamoto Y, Figueiredo JL, Christen T, Swirski FK, Libby P, Weissleder R, Nahrendorf M.

Circ Cardiovasc Imaging. 2013 Jul;6(4):568-73. doi: 10.1161/CIRCIMAGING.113.000481. Epub 2013 Jun 14.


Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection.

Daly KP, Dearling JL, Seto T, Dunning P, Fahey F, Packard AB, Briscoe DM.

Transplantation. 2015 Sep;99(9):e132-9. doi: 10.1097/TP.0000000000000618.


Detection of macrophages in aortic aneurysms by nanoparticle positron emission tomography-computed tomography.

Nahrendorf M, Keliher E, Marinelli B, Leuschner F, Robbins CS, Gerszten RE, Pittet MJ, Swirski FK, Weissleder R.

Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):750-7. doi: 10.1161/ATVBAHA.110.221499. Epub 2011 Jan 20.


Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.

Iida S, Omoto K, Kanemitsu I, Setoguchi K, Ishida H, Tanabe K, Suzuki T, Tashiro Y, Kishimoto H, Abe R.

Exp Clin Transplant. 2012 Aug;10(4):375-85. doi: 10.6002/ect.2011.0159. Epub 2012 Jul 2.


18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.

Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R.

JACC Cardiovasc Imaging. 2009 Oct;2(10):1213-22. doi: 10.1016/j.jcmg.2009.04.016.


NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.

van der Touw W, Burrell B, Lal G, Bromberg JS.

Transplantation. 2012 Sep 27;94(6):575-84.


New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.

Richter M, Skupin M, Grabs R, Schramm D, Richter H, Olbrich HG.

J Heart Lung Transplant. 2000 Nov;19(11):1047-55.


Increased T cell glucose uptake reflects acute rejection in lung grafts.

Chen DL, Wang X, Yamamoto S, Carpenter D, Engle JT, Li W, Lin X, Kreisel D, Krupnick AS, Huang HJ, Gelman AE.

Am J Transplant. 2013 Oct;13(10):2540-9. doi: 10.1111/ajt.12389. Epub 2013 Aug 8.


Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.

Shimizu K, Libby P, Rocha VZ, Folco EJ, Shubiki R, Grabie N, Jang S, Lichtman AH, Shimizu A, Hogg N, Simon DI, Mitchell RN, Croce K.

Circulation. 2011 Dec 20;124(25):2920-32. doi: 10.1161/CIRCULATIONAHA.110.009910. Epub 2011 Dec 5.


Pretreatment of transfused donor splenocytes and allografts with mitomycin C attenuates acute rejection in heart transplantation in mice.

Liu L, Wang F, Zheng Y, Yuan X, Wang D, Zeng W, He X, Wang C, Deng S.

Transplant Proc. 2014 May;46(4):1169-74. doi: 10.1016/j.transproceed.2013.11.052.


Molecular imaging of innate immune cell function in transplant rejection.

Christen T, Nahrendorf M, Wildgruber M, Swirski FK, Aikawa E, Waterman P, Shimizu K, Weissleder R, Libby P.

Circulation. 2009 Apr 14;119(14):1925-32. doi: 10.1161/CIRCULATIONAHA.108.796888. Epub 2009 Mar 30.


Haptoglobin enhances cardiac transplant rejection.

Shen H, Heuzey E, Mori DN, Wong CK, Colangelo CM, Chung LM, Bruce C, Slizovskiy IB, Booth CJ, Kreisel D, Goldstein DR.

Circ Res. 2015 May 8;116(10):1670-9. doi: 10.1161/CIRCRESAHA.116.305406. Epub 2015 Mar 23.


Inhibition of the purinergic pathway prolongs mouse lung allograft survival.

Liu K, Vergani A, Zhao P, Ben Nasr M, Wu X, Iken K, Jiang D, Su X, Fotino C, Fiorina P, Visner GA.

Am J Respir Cell Mol Biol. 2014 Aug;51(2):300-10. doi: 10.1165/rcmb.2013-0362OC.


Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.

Wang H, Hosiawa KA, Min W, Yang J, Zhang X, Garcia B, Ichim TE, Zhou D, Lian D, Kelvin DJ, Zhong R.

J Immunol. 2003 Oct 1;171(7):3823-36.


Galectin-7 in cardiac allografts in mice: increased expression compared with isografts and localization in infiltrating lymphocytes and vascular endothelial cells.

Luo Z, Ji Y, Zhou H, Huang X, Fang J, Guo H, Pan T, Chen ZK.

Transplant Proc. 2013 Mar;45(2):630-4. doi: 10.1016/j.transproceed.2012.12.005.


Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.

Haeryfar SM, Lan Z, Leon-Ponte M, Duffy KR, Ge W, Liu W, Mele T, Garcia B, Wang H.

Transplantation. 2008 Aug 15;86(3):460-8. doi: 10.1097/TP.0b013e3181806b72.


Long-term cardiac allograft survival across an MHC mismatch after "pruning" of alloreactive CD4 T cells.

Hu M, Watson D, Zhang GY, Graf N, Wang YM, Sartor M, Howden B, Fletcher J, Alexander SI.

J Immunol. 2008 May 15;180(10):6593-603.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk